Insulin Safety Protocol Research: What the Study Found

Medication errors involving insulin are among the most preventable — and most dangerous — in clinical settings. Yet a striking finding from a newly published study suggests that healthcare professionals may be significantly underprepared when it comes to safe insulin preparation and administration. Published in Revista Brasileira de Enfermagem (May 2026), the study by Moreira, Carvalho, Freitas, and colleagues set out to develop and validate a comprehensive protocol designed to close that knowledge gap — with results that carry meaningful implications for patient safety worldwide.

What This Study Found

This methodological study, conducted between September 2022 and May 2024, unfolded in two distinct phases. In the first phase, researchers developed a protocol for safe insulin preparation and administration and submitted it for validation by a panel of 46 healthcare experts. Validation was conducted using the AGREE II instrument, a widely recognized framework for assessing the quality and methodological rigor of clinical guidelines and protocols.

The results of that validation process were notably strong. The protocol achieved a Content Validity Index of 97.83 to 100 (p<0.001), indicating near-universal agreement among experts regarding the relevance and clarity of the content. The overall quality score reached 95.7% (6.70 ± 0.47), and all six AGREE II domains scored at or above 90.0% — a threshold generally considered to reflect high methodological quality. Internal consistency and reproducibility were also confirmed as robust, with a Cronbach's alpha of 0.94 and McDonald's omega of 0.95.

In the second phase, 40 healthcare professionals in Fortaleza, Brazil, underwent structured training using the newly validated protocol. Pre- and post-training assessments measured knowledge acquisition. Before training, participants answered correctly only 32% of the time. After training with the protocol, that figure rose to 70% — a statistically significant improvement. Researchers suggest these findings indicate that the protocol is not only a high-quality reference document but also an effective educational tool capable of substantially improving clinical knowledge in a real-world setting.

Clinical Significance

Insulin is classified as a high-alert medication by patient safety organizations globally, meaning errors in its preparation or administration carry a disproportionately high risk of serious patient harm. Dosing errors, incorrect storage, improper injection technique, and confusion between insulin types are among the most common — and most consequential — mistakes that can occur in both hospital and outpatient settings.

The researchers note that the development of a validated, evidence-based protocol addresses a recognized gap in standardized guidance for insulin handling. Unlike general medication safety guidelines, a protocol specifically focused on insulin preparation and administration can account for the unique pharmacological properties of different insulin formulations, the technical nuances of injection devices, and the time-sensitive nature of insulin dosing in acute care environments.

The study suggests that structured, protocol-driven training has the potential to meaningfully reduce the risk of insulin-related adverse events. The near-doubling of correct responses among trained professionals — from 32% to 70% — points to a significant knowledge deficit that existed prior to the intervention, as well as the protocol's capacity to address it. Researchers emphasize, however, that ongoing education and regular protocol reinforcement are likely necessary to maintain improvements in clinical practice over time.

It is worth noting that this study was conducted in a specific geographic and institutional context (Fortaleza, Brazil), and researchers acknowledge that further validation across diverse healthcare systems and professional populations would strengthen the generalizability of these findings.

Current Access and Compliance Context

Despite the existence of international diabetes management guidelines from organizations such as the American Diabetes Association and the International Diabetes Federation, standardized protocols specifically governing the step-by-step preparation and administration of insulin in clinical settings remain inconsistently implemented across healthcare institutions. This gap is particularly pronounced in resource-limited environments, where formal training programs may be irregular or absent.

Healthcare professionals who administer insulin — including nurses, physicians, pharmacists, and allied health staff — often receive initial training during their professional education, but may not receive regular updates as insulin delivery technologies evolve. Newer insulin formulations, smart pen devices, and continuous subcutaneous insulin infusion systems have introduced additional layers of complexity that existing training frameworks may not fully address.

The study's use of the AGREE II instrument for protocol validation is also clinically significant. AGREE II is the same framework used to evaluate national and international clinical practice guidelines, lending the protocol a level of methodological credibility that supports its potential adoption by healthcare institutions seeking to formalize insulin safety practices.

What Patients Should Know

For the estimated 537 million adults living with diabetes worldwide — many of whom rely on insulin therapy — the quality of insulin administration practices directly affects treatment outcomes. Patients and caregivers who self-administer insulin at home are also subject to the same risks of technique errors, storage mismanagement, and dosing confusion that affect clinical settings.

While this study focused on healthcare professionals rather than patients, its findings underscore the importance of receiving insulin education from trained, knowledgeable providers. Patients should feel empowered to ask their healthcare team specific questions about insulin preparation, injection technique, storage requirements, and what to do in the event of a missed dose or suspected error.

If you are currently on insulin therapy or have been told that insulin may be appropriate for your condition, working with a qualified healthcare provider who stays current with evidence-based protocols is an important part of safe, effective care. The study suggests that provider training significantly impacts the quality of insulin-related clinical knowledge — making the credentials and ongoing education of your care team a relevant consideration.

Patients should also be aware that insulin therapy, while established and well-characterized, requires individualized management. No protocol or general guideline replaces a personalized treatment plan developed in collaboration with a licensed clinician who understands your specific health history, goals, and risk factors.

Conclusion

The research by Moreira and colleagues represents a meaningful contribution to the field of medication safety, offering a rigorously validated protocol that demonstrably improves healthcare professionals' knowledge of safe insulin practices. The study suggests that investing in structured, evidence-based training tools can substantially reduce the knowledge gaps that contribute to preventable insulin-related errors — a finding with implications for hospital systems, outpatient clinics, and diabetes care programs globally.

As the science of peptide and hormone therapies continues to evolve, access to qualified, informed healthcare providers remains essential. If you are seeking a knowledgeable clinician to guide your diabetes management or insulin therapy, we encourage you to connect with a qualified professional through our directory. Find a doctor at peptideassociation.org/find-a-doctor and take the next step toward informed, evidence-based care.

---

Medical Disclaimer: This article is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The content summarizes findings from a published research study and should not be used as a substitute for professional medical guidance. Always consult a licensed and qualified healthcare provider regarding any questions you may have about a medical condition, medication, or treatment plan.

---

Citation (AMA Format): Moreira TR, Carvalho REFL, Freitas CHA, et al. Development of a protocol on safe practices for insulin preparation and administration. Revista Brasileira de Enfermagem. 2026;(published May 2026). doi:10.1590/0034-7167-2025-0345. PMID: 42138841.